Justin Feigelman

Critic
DISC Type : C

Director, Clinical Pharmacology at Gilead Sciences

San Francisco Bay Area, United States

Overview

Justin Feigelman is the Director of Clinical Pharmacology at Gilead Sciences, where he leads the development of Quantitative Systems Pharmacology (QSP) models. His expertise lies in creating complex models for virology and inflammation to support drug development. He holds a PhD from the Technical University of Munich and a B. A. in Physics from UC Berkeley.

He developed a comprehensive QSP model of acute Hepatitis B virus infection to provide mechanistic insights into how the virus progresses and inform the design of novel therapies.

Personality Overview

Information Seeker

ROI Driven

Critic

They don’t appreciate bells and whistles unless backed by data.  They prefer to analyze logically and value objective facts over emotions. They are quite likely to negotiate on pricing or other key terms.

Topics They Care About

Quantitative Systems Pharmacology
He leads a QSP group at Gilead, has numerous publications on the topic, and is focused on applying these models to support clinical programs and decision-making.
Viral Dynamics Modeling
His recent publications focus on creating detailed models of Hepatitis B and HIV to understand the interplay between viral replication, immune response, and therapeutic interventions.
Drug Program Design
His work aims to provide mechanistic insights that support clinical program design for a wide range of novel therapies during the drug development process.

Media Appearances

Justin has no verified media appearances

Work History

9-2024
Director, Clinical Pharmacology at Gilead Sciences
9-2023
Sr. Clinical Pharmacologist II at Gilead Sciences
5-2022 - 9-2023
Associate Director of Quantitative Pharmacology at Regeneron
5-2021 - 5-2022
Senior Scientist, Modeling and Simulation at Genentech
10-2019 - 5-2021
Scientist, Modeling and Simulation at Genentech

Education

2011 - 2015
Doctor of Philosophy (PhD) from Technical University of Munich
2009 - 2011
MS from ETH Zürich

More Information

Social Presence :

Prographics :

Exp : 14 Location : San Francisco Bay Area, United States Job Level : Mid-senior Designation : Director, Clinical Pharmacology at Gilead Sciences
URL has been copied!

Insights For Selling To Justin

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Be ready to answer many clarity-seeking questions and requests for information
  • Be formal and objective, they will appreciate it more

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Don’t try too hard to build a relationship with them
  • Do not use very emotional or colorful language

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Justin is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Justin

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Justin move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Justin take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Justin

Personality Compatibility


Other Gilead Sciences Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.